Literature DB >> 7902408

Enhanced antigen presentation in the absence of the invariant chain endosomal localization signal.

M S Anderson1, K Swier, L Arneson, J Miller.   

Abstract

The cytosolic tail of the major histocompatibility complex class II-associated invariant chain (Ii) molecule is thought to contain the endosomal localization signal that directs and/or retains newly synthesized class II within the endosomal antigen processing compartment. To determine the role of this signal in class II transport and antigen presentation we have generated class II-positive L cell transfectants that coexpress wild type or truncated forms of Ii. Deletion of the endosomal localization signal from Ii results in rapid transport of class II-Ii complexes to the cell surface. Once at the cell surface, the complex is efficiently internalized, Ii is degraded, and class II free of Ii is recycled back to the plasma membrane. Interestingly, the truncated form of Ii is still able to increase the efficiency of antigen presentation to T cells. These data suggest that the ability of Ii to enhance antigen presentation is not limited to Golgi apparatus-endosomal sorting and raise the possibility that endocytosed class II can form immunogenic complexes with newly processed antigen.

Mesh:

Substances:

Year:  1993        PMID: 7902408      PMCID: PMC2191285          DOI: 10.1084/jem.178.6.1959

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  51 in total

1.  Invariant chain can function as a chaperone protein for class II major histocompatibility complex molecules.

Authors:  M S Anderson; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

2.  Intracellular class II HLA antigens are accessible to transferrin-neuraminidase conjugates internalized by receptor-mediated endocytosis.

Authors:  P Cresswell
Journal:  Proc Natl Acad Sci U S A       Date:  1985-12       Impact factor: 11.205

3.  Properties of monoclonal antibodies to mouse Ig allotypes, H-2, and Ia antigens.

Authors:  V T Oi; P P Jones; J W Goding; L A Herzenberg; L A Herzenberg
Journal:  Curr Top Microbiol Immunol       Date:  1978       Impact factor: 4.291

4.  A shared alloantigenic determinant on Ia antigens encoded by the I-A and I-E subregions: evidence for I region gene duplication.

Authors:  A Bhattacharya; M E Dorf; T A Springer
Journal:  J Immunol       Date:  1981-12       Impact factor: 5.422

5.  Murine Ia-associated invariant chain's processing to complex oligosaccharide forms and its dissociation from the I-Ak complex.

Authors:  G D Holt; S J Swiedler; J H Freed; G W Hart
Journal:  J Immunol       Date:  1985-07       Impact factor: 5.422

6.  Processing of lysozyme by macrophages: identification of the determinant recognized by two T-cell hybridomas.

Authors:  P M Allen; D J Strydom; E R Unanue
Journal:  Proc Natl Acad Sci U S A       Date:  1984-04       Impact factor: 11.205

7.  Primary structure of the gene for the murine Ia antigen-associated invariant chains (Ii). An alternatively spliced exon encodes a cysteine-rich domain highly homologous to a repetitive sequence of thyroglobulin.

Authors:  N Koch; W Lauer; J Habicht; B Dobberstein
Journal:  EMBO J       Date:  1987-06       Impact factor: 11.598

8.  Antigen recognition by H-2-restricted T cells. I. Cell-free antigen processing.

Authors:  R Shimonkevitz; J Kappler; P Marrack; H Grey
Journal:  J Exp Med       Date:  1983-08-01       Impact factor: 14.307

9.  The antigen-specific, major histocompatibility complex-restricted receptor on T cells. VI. An antibody to a receptor allotype.

Authors:  K Haskins; C Hannum; J White; N Roehm; R Kubo; J Kappler; P Marrack
Journal:  J Exp Med       Date:  1984-08-01       Impact factor: 14.307

10.  Antigen-inducible, H-2-restricted, interleukin-2-producing T cell hybridomas. Lack of independent antigen and H-2 recognition.

Authors:  J W Kappler; B Skidmore; J White; P Marrack
Journal:  J Exp Med       Date:  1981-05-01       Impact factor: 14.307

View more
  12 in total

1.  Introducing endogenous antigens into the major histocompatibility complex (MHC) class II presentation pathway. Both Ii mediated inhibition and enhancement of endogenous peptide/MHC class II presentation require the same Ii domains.

Authors:  K Frauwirth; N Shastri
Journal:  Immunology       Date:  2001-04       Impact factor: 7.397

2.  LFA-1-mediated T cell costimulation through increased localization of TCR/class II complexes to the central supramolecular activation cluster and exclusion of CD45 from the immunological synapse.

Authors:  Beth Graf; Timothy Bushnell; Jim Miller
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

3.  The chondroitin sulfate form of invariant chain trimerizes with conventional invariant chain and these complexes are rapidly transported from the trans-Golgi network to the cell surface.

Authors:  Lynne S Arneson; Jim Miller
Journal:  Biochem J       Date:  2007-08-15       Impact factor: 3.857

4.  Major histocompatibility complex class II-peptide complexes internalize using a clathrin- and dynamin-independent endocytosis pathway.

Authors:  Even Walseng; Oddmund Bakke; Paul A Roche
Journal:  J Biol Chem       Date:  2008-03-31       Impact factor: 5.157

5.  Uveitogenic epitopes of retinal S-antigen are generated in vivo via an alternative antigen-presentation pathway.

Authors:  J Liversidge; R Dawson; A D Dick; J V Forrester
Journal:  Immunology       Date:  1998-06       Impact factor: 7.397

Review 6.  Endosomal localization of MHC class II-invariant chain complexes.

Authors:  J Miller
Journal:  Immunol Res       Date:  1994       Impact factor: 2.829

7.  Proteolysis of major histocompatibility complex class II-associated invariant chain is regulated by the alternatively spliced gene product, p41.

Authors:  B Fineschi; L S Arneson; M F Naujokas; J Miller
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-24       Impact factor: 11.205

8.  Expression of endogenous peptide-major histocompatibility complex class II complexes derived from invariant chain-antigen fusion proteins.

Authors:  S Sanderson; K Frauwirth; N Shastri
Journal:  Proc Natl Acad Sci U S A       Date:  1995-08-01       Impact factor: 11.205

9.  Selective release of some invariant chain-derived peptides from HLA-DR1 molecules at endosomal pH.

Authors:  R G Urban; R M Chicz; J L Strominger
Journal:  J Exp Med       Date:  1994-08-01       Impact factor: 14.307

10.  Binding of major histocompatibility complex class II to the invariant chain-derived peptide, CLIP, is regulated by allelic polymorphism in class II.

Authors:  A Sette; S Southwood; J Miller; E Appella
Journal:  J Exp Med       Date:  1995-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.